Paper36910628
Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis.
Caddeo A and 8 others. Front Oncol, 2023. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis. Papers, record 36910628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36910628
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26558795 | Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis. | Hepatol Int | 2016 | https://conductscience.org/library/papers/26558795 | PubMed |
| 2 | 25330987 | A thyroid hormone receptor/KLF9 axis in human hepatocytes and pluripotent stem cells. | Stem Cells | 2015 | https://conductscience.org/library/papers/25330987 | PubMed |
| 3 | 7382552 | Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. | Mayo Clin Proc | 1980 | https://conductscience.org/library/papers/7382552 | PubMed |
| 4 | 30266282 | Burden of liver diseases in the world. | J Hepatol | 2019 | https://conductscience.org/library/papers/30266282 | PubMed |
| 5 | 18279024 | Metabolic effects of thyroid hormone derivatives. | Thyroid | 2008 | https://conductscience.org/library/papers/18279024 | PubMed |
| 6 | 33687750 | An Underdiagnosed Hypothyroidism and Its Clinical Significance in Patients with Advanced Hepatocellular Carcinoma. | Oncologist | 2021 | https://conductscience.org/library/papers/33687750 | PubMed |
| 7 | 18434432 | Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats. | FASEB J | 2008 | https://conductscience.org/library/papers/18434432 | PubMed |
| 8 | 30496129 | Reduced expression of thyroid hormone receptor β in human nonalcoholic steatohepatitis. | Endocr Connect | 2018 | https://conductscience.org/library/papers/30496129 | PubMed |
| 9 | 27070090 | Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis. | Oncotarget | 2016 | https://conductscience.org/library/papers/27070090 | PubMed |
| 10 | 28081779 | Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study. | Metabolism | 2017 | https://conductscience.org/library/papers/28081779 | PubMed |
| 11 | 19125327 | Cardiac hypertrophy and thyroid hormone signaling. | Heart Fail Rev | 2010 | https://conductscience.org/library/papers/19125327 | PubMed |
| 12 | 28823829 | Subclinical Hypothyroidism and Low-Normal Thyroid Function Are Associated With Nonalcoholic Steatohepatitis and Fibrosis. | Clin Gastroenterol Hepatol | 2018 | https://conductscience.org/library/papers/28823829 | PubMed |
| 13 | 27653365 | Thyroid hormone suppresses hepatocarcinogenesis via DAPK2 and SQSTM1-dependent selective autophagy. | Autophagy | 2016 | https://conductscience.org/library/papers/27653365 | PubMed |
| 14 | 19072834 | Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist. | Hepatology | 2009 | https://conductscience.org/library/papers/19072834 | PubMed |
| 15 | 32782275 | Targeted therapy for hepatocellular carcinoma. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/32782275 | PubMed |
| 16 | 35317606 | Thyroid Hormone Decreases Hepatic Steatosis, Inflammation, and Fibrosis in a Dietary Mouse Model of Nonalcoholic Steatohepatitis. | Thyroid | 2022 | https://conductscience.org/library/papers/35317606 | PubMed |
| 17 | 24712661 | Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β agonist in clinical trials for the treatment of dyslipidemia. | J Med Chem | 2014 | https://conductscience.org/library/papers/24712661 | PubMed |
| 18 | 17008133 | Hypothyroidism: a possible risk factor for liver cancer in patients with no known underlying cause of liver disease. | Clin Gastroenterol Hepatol | 2007 | https://conductscience.org/library/papers/17008133 | PubMed |
| 19 | 17387171 | CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17387171 | PubMed |
| 20 | 21994129 | Dickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells. | Hepatology | 2012 | https://conductscience.org/library/papers/21994129 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42734678 | Endocrine meets hepatic: the thyroid-liver axis in health and disease-an overview. | Wien Med Wochenschr | 2026 | https://conductscience.org/library/papers/42734678 | PubMed |
| 42437256 | Thyroid-Liver Axis: Mechanistic Insights and Clinical Implications. | Cureus | 2026 | https://conductscience.org/library/papers/42437256 | PubMed |
| 41975310 | In vivo and molecular docking investigation of the novel anti-inflammatory and mitochondrial mechanisms underlying the renoprotective effects of resmetirom and curcumin in gentamicin-induced renal toxicity in rats. | BMC Nephrol | 2026 | https://conductscience.org/library/papers/41975310 | PubMed |
| 41961637 | Risk and prognosis of HCC in patients with thyroid disease: A nationwide cohort study. | Hepatol Commun | 2025 | https://conductscience.org/library/papers/41961637 | PubMed |
| 41321669 | Targeting THR-β for MASLD: Mechanisms and Drug Development. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/41321669 | PubMed |
| 41007643 | Resmetirom for MASH: A Comprehensive Review of a Novel Therapeutic Frontier. | Biomedicines | 2025 | https://conductscience.org/library/papers/41007643 | PubMed |
| 40986164 | Resmetirom: The First FDA-Approved Drug for Metabolic Dysfunction-Associated Steatohepatitis (MASH) with a Perspective on Precision Medicine. | Clin Drug Investig | 2025 | https://conductscience.org/library/papers/40986164 | PubMed |
| 40041922 | Drug discovery targeting thyroid hormone receptor β (THRβ) for the treatment of liver diseases and other medical indications. | Acta Pharm Sin B | 2025 | https://conductscience.org/library/papers/40041922 | PubMed |
| 40016726 | Hypothyroidism/subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease: advances in mechanism and treatment. | Lipids Health Dis | 2025 | https://conductscience.org/library/papers/40016726 | PubMed |
| 39420154 | Actions of thyroid hormones and thyromimetics on the liver. | Nat Rev Gastroenterol Hepatol | 2025 | https://conductscience.org/library/papers/39420154 | PubMed |
| 37765015 | Synthetic Thyroid Hormone Receptor-β Agonists Promote Oligodendrocyte Precursor Cell Differentiation in the Presence of Inflammatory Challenges. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37765015 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| G6PC1 | 2538 | PubTator's text mining | https://conductscience.org/library/genes/2538 | NCBI Gene |
| G6PD | 2539 | PubTator's text mining | https://conductscience.org/library/genes/2539 | NCBI Gene |
| KLF9 | 687 | PubTator's text mining | https://conductscience.org/library/genes/687 | NCBI Gene |
| THRA | 7067 | PubTator's text mining | https://conductscience.org/library/genes/7067 | NCBI Gene |
| THRB | 7068 | PubTator's text mining | https://conductscience.org/library/genes/7068 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36910628
GET https://conductscience.org/api/papers/v1/36910628/references?page=2